Exact Mass: 262.0621

Exact Mass Matches: 262.0621

Found 111 metabolites which its exact mass value is equals to given mass value 262.0621, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

5-Fluorouridine

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-fluoro-1,2,3,4-tetrahydropyrimidine-2,4-dione

C9H11FN2O6 (262.0601)


5-Fluorouridine is a metabolite of fluorouracil. Fluorouracil (5-FU or f5U) (sold under the brand names Adrucil, Carac, Efudix, Efudex and Fluoroplex) is a drug that is a pyrimidine analog which is used in the treatment of cancer. It is a suicide inhibitor and works through irreversible inhibition of thymidylate synthase. It belongs to the family of drugs called antimetabolites. It is typically administered with leucovorin. (Wikipedia) 5-Fluorouridine, a metabolite of 5-fluorouracil (HY-90006), is a potent ribozyme self-cleavage inhibitor. 5-Fluorouridine incorporates into both total and poly A RNA and has antiproliferative activity. 5-Fluorouridine induces apoptosis[1][2][3].

   

Cinoxacin

5-Ethyl-8-oxo-5,8-dihydro-1,3-dioxa-5,6-diaza-cyclopenta[b]naphthalene-7-carboxylic acid

C12H10N2O5 (262.059)


Cinoxacin is only found in individuals that have used or taken this drug. It is a synthetic antimicrobial related to oxolinic acid and nalidixic acid and used in urinary tract infections. [PubChem]Evidence exists that cinoxacin binds strongly, but reversibly, to DNA, interfering with synthesis of RNA and, consequently, with protein synthesis. It appears to also inhibit DNA gyrase. This enzyme is necessary for proper replicated DNA separation. By inhibiting this enzyme, DNA replication and cell division is inhibited. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000890 - Anti-Infective Agents D004791 - Enzyme Inhibitors

   

Carbadox

N-[(1E)-(1,4-dioxo-1λ⁵,4λ⁵-quinoxalin-2-yl)methylidene]methoxycarbohydrazide

C11H10N4O4 (262.0702)


Carbadox is found in animal foods. Animal growth promoter especially for pigs. Banned in the EU. Carbadox is a permitted in USA subject to a 45-day withdrawal period (2001) Carbadox is a drug that combats parasite infection. In early 2004 it was banned by the Canadian government as a livestock feed additive and for human consumption. The European Union also forbids the use of Carbadox at any level. It is approved in the United States for use in swine for up to 42 days before slaughter Animal growth promoter especies for pigs. Banned in the EU. Permitted in USA subject to a 45-day withdrawal period (2001) [DFC] D009676 - Noxae > D002273 - Carcinogens D009676 - Noxae > D009153 - Mutagens D000890 - Anti-Infective Agents

   

1-beta-D-Arabinofuranosyl-5-fluoro-(1H,3H)-pyrimidine-2,4-dione

1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-fluoro-1,2,3,4-tetrahydropyrimidine-2,4-dione

C9H11FN2O6 (262.0601)


   

7-Carboxynalidixic acid

8-ethyl-5-oxo-5,8-dihydro-1,8-naphthyridine-2,6-dicarboxylic acid

C12H10N2O5 (262.059)


   

Mecadox

2-({[(methoxycarbonyl)amino]imino}methyl)quinoxaline-1,4-diium-1,4-bis(olate)

C11H10N4O4 (262.0702)


   

Carboxymethyl cellulose, sodium salt

Sodium 2,3,4,5,6-pentahydroxyhexanal acetic acid

C8H15NaO8 (262.0665)


It is used as a food additive .

   

Lanceolatin B (flavonoid)

Lanceolatin B (flavonoid)

C17H10O3 (262.063)


   

Furano[2,3:6,7]aurone

Furano [ 2",3":6,7 ] aurone

C17H10O3 (262.063)


A member of the class of aurones that is aurone with a furan ring fused across positions C-6, and -7.

   
   
   

LANCEOLATIN B

LANCEOLATIN B

C17H10O3 (262.063)


   
   

ethyl Z-3-bromo-2-nonenoate

ethyl Z-3-bromo-2-nonenoate

C11H19BrO2 (262.0568)


   

2-methoxy-1,8-pyrenedione

2-methoxy-1,8-pyrenedione

C17H10O3 (262.063)


   

LMPK12130001

LMPK12130001

C17H10O3 (262.063)


   

Di-Et ester,2,5:3,4-di-O-methylene-Galactaric acid

Di-Et ester,2,5:3,4-di-O-methylene-Galactaric acid

C10H14O8 (262.0689)


   

Carbadox

Carbadox

C11H10N4O4 (262.0702)


CONFIDENCE standard compound; INTERNAL_ID 1175

   

cinoxacin

cinoxacin

C12H10N2O5 (262.059)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000890 - Anti-Infective Agents D004791 - Enzyme Inhibitors relative retention time with respect to 9-anthracene Carboxylic Acid is 0.746 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.738 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.740

   

2-phenylfuro[2,3-h]chromen-4-one

NCGC00384489-01!2-phenylfuro[2,3-h]chromen-4-one

C17H10O3 (262.063)


   

2-phenylfuro[2,3-h]chromen-4-one [IIN-based on: CCMSLIB00000848798]

NCGC00384489-01!2-phenylfuro[2,3-h]chromen-4-one [IIN-based on: CCMSLIB00000848798]

C17H10O3 (262.063)


   

2-phenylfuro[2,3-h]chromen-4-one [IIN-based: Match]

NCGC00384489-01!2-phenylfuro[2,3-h]chromen-4-one [IIN-based: Match]

C17H10O3 (262.063)


   

LANCEOLATIN B_major

LANCEOLATIN B_major

C17H10O3 (262.063)


   

7-Carboxynalidixic acid

7-Carboxynalidixic acid

C12H10N2O5 (262.059)


   

2-Thiopheneacetic acid, 5-(hydroxyphenylmethyl)-α-methyl-

2-Thiopheneacetic acid, 5-(hydroxyphenylmethyl)-α-methyl-

C14H14O3S (262.0664)


   

3-(4-Nitrobenzyl)-5-hydroxy-3H-imidazole-4-carboxamide

3-(4-Nitrobenzyl)-5-hydroxy-3H-imidazole-4-carboxamide

C11H10N4O4 (262.0702)


   

1,1,2,2-Ethanetetracarboxylic acid, tetramethyl ester

1,1,2,2-Ethanetetracarboxylic acid, tetramethyl ester

C10H14O8 (262.0689)


   

2-(4-NITRO-PHENYL)-OXAZOLE-4-CARBOXYLIC ACID ETHYL ESTER

2-(4-NITRO-PHENYL)-OXAZOLE-4-CARBOXYLIC ACID ETHYL ESTER

C12H10N2O5 (262.059)


   

5-BROMO-2-METHOXYBENZENESULFONYLCHLORIDE

5-BROMO-2-METHOXYBENZENESULFONYLCHLORIDE

C11H16ClO3P (262.0526)


   

4-Benzyloxy-2-chlorophenylboronic acid

4-Benzyloxy-2-chlorophenylboronic acid

C13H12BClO3 (262.0568)


   

Ethyl 4-hydroxy-6-(methylsulfanyl)-2-naphthoate

Ethyl 4-hydroxy-6-(methylsulfanyl)-2-naphthoate

C14H14O3S (262.0664)


   

2-(4-fluorophenyl)-1-(2,4,6-trihydroxyphenyl)ethanone

2-(4-fluorophenyl)-1-(2,4,6-trihydroxyphenyl)ethanone

C14H11FO4 (262.0641)


   

2-(3-TRIFLUOROMETHYL-PHENYLAMINO)-BENZONITRILE

2-(3-TRIFLUOROMETHYL-PHENYLAMINO)-BENZONITRILE

C14H9F3N2 (262.0718)


   

(2R)-4-amino-2-(1,3-dioxoisoindol-2-yl)-4-oxobutanoic acid

(2R)-4-amino-2-(1,3-dioxoisoindol-2-yl)-4-oxobutanoic acid

C12H10N2O5 (262.059)


   

N-ALPHA-PHTHALYL-L-ASPARAGINE

N-ALPHA-PHTHALYL-L-ASPARAGINE

C12H10N2O5 (262.059)


   

5-(4-Nitrophenyl)-oxazole-4-carboxylic acid ethyl ester

5-(4-Nitrophenyl)-oxazole-4-carboxylic acid ethyl ester

C12H10N2O5 (262.059)


   

(3-((2-CHLOROPHENOXY)METHYL)PHENYL)BORONIC ACID

(3-((2-CHLOROPHENOXY)METHYL)PHENYL)BORONIC ACID

C13H12BClO3 (262.0568)


   

(4-((2-CHLOROPHENOXY)METHYL)PHENYL)BORONIC ACID

(4-((2-CHLOROPHENOXY)METHYL)PHENYL)BORONIC ACID

C13H12BClO3 (262.0568)


   

(2-((4-CHLOROPHENOXY)METHYL)PHENYL)BORONIC ACID

(2-((4-CHLOROPHENOXY)METHYL)PHENYL)BORONIC ACID

C13H12BClO3 (262.0568)


   

(4-((4-CHLOROPHENOXY)METHYL)PHENYL)BORONIC ACID

(4-((4-CHLOROPHENOXY)METHYL)PHENYL)BORONIC ACID

C13H12BClO3 (262.0568)


   

(3-((3-CHLOROPHENOXY)METHYL)PHENYL)BORONIC ACID

(3-((3-CHLOROPHENOXY)METHYL)PHENYL)BORONIC ACID

C13H12BClO3 (262.0568)


   

(2-((3-CHLOROPHENOXY)METHYL)PHENYL)BORONIC ACID

(2-((3-CHLOROPHENOXY)METHYL)PHENYL)BORONIC ACID

C13H12BClO3 (262.0568)


   

(4-((3-CHLOROPHENOXY)METHYL)PHENYL)BORONIC ACID

(4-((3-CHLOROPHENOXY)METHYL)PHENYL)BORONIC ACID

C13H12BClO3 (262.0568)


   

(4-((2-CHLOROBENZYL)OXY)PHENYL)BORONIC ACID

(4-((2-CHLOROBENZYL)OXY)PHENYL)BORONIC ACID

C13H12BClO3 (262.0568)


   

(2-((4-CHLOROBENZYL)OXY)PHENYL)BORONIC ACID

(2-((4-CHLOROBENZYL)OXY)PHENYL)BORONIC ACID

C13H12BClO3 (262.0568)


   

(2-((2-Chlorophenoxy)methyl)phenyl)boronic acid

(2-((2-Chlorophenoxy)methyl)phenyl)boronic acid

C13H12BClO3 (262.0568)


   

3-(3-Chlorobenzyloxy)phenylboronic acid

3-(3-Chlorobenzyloxy)phenylboronic acid

C13H12BClO3 (262.0568)


   

2-(3-CHLOROBENZYLOXY)PHENYLBORONIC ACID

2-(3-CHLOROBENZYLOXY)PHENYLBORONIC ACID

C13H12BClO3 (262.0568)


   

4-(4-CHLOROBENZYLOXY)PHENYLBORONIC ACID

4-(4-CHLOROBENZYLOXY)PHENYLBORONIC ACID

C13H12BClO3 (262.0568)


   

ethyl 3-formyl-7-nitro-1h-indole-2-carboxylate

ethyl 3-formyl-7-nitro-1h-indole-2-carboxylate

C12H10N2O5 (262.059)


   

(3-((4-CHLOROPHENOXY)METHYL)PHENYL)BORONIC ACID

(3-((4-CHLOROPHENOXY)METHYL)PHENYL)BORONIC ACID

C13H12BClO3 (262.0568)


   

(4-((3-CHLOROBENZYL)OXY)PHENYL)BORONIC ACID

(4-((3-CHLOROBENZYL)OXY)PHENYL)BORONIC ACID

C13H12BClO3 (262.0568)


   

Bis(4-methoxyphenyl) sulfoxide

Bis(4-methoxyphenyl) sulfoxide

C14H14O3S (262.0664)


   

3-(4-CHLOROBENZYLOXY)PHENYLBORONIC ACID

3-(4-CHLOROBENZYLOXY)PHENYLBORONIC ACID

C13H12BClO3 (262.0568)


   

3-(2-CHLOROBENZYLOXY)PHENYLBORONIC ACID

3-(2-CHLOROBENZYLOXY)PHENYLBORONIC ACID

C13H12BClO3 (262.0568)


   

2-(2-CHLOROBENZYLOXY)PHENYLBORONIC ACID

2-(2-CHLOROBENZYLOXY)PHENYLBORONIC ACID

C13H12BClO3 (262.0568)


   

2,4(1H,3H)-Pyrimidinedione,1-b-D-arabinofuranosyl-5-fluoro-

2,4(1H,3H)-Pyrimidinedione,1-b-D-arabinofuranosyl-5-fluoro-

C9H11FN2O6 (262.0601)


   

1-chloro-2-(diethoxyphosphorylmethyl)benzene

1-chloro-2-(diethoxyphosphorylmethyl)benzene

C11H16ClO3P (262.0526)


   

1-(4-TRIFLUOROMETHYLPHENYL)-1H-BENZOIMIDAZOLE

1-(4-TRIFLUOROMETHYLPHENYL)-1H-BENZOIMIDAZOLE

C14H9F3N2 (262.0718)


   

(3-(BENZYLOXY)-4-CHLOROPHENYL)BORONIC ACID

(3-(BENZYLOXY)-4-CHLOROPHENYL)BORONIC ACID

C13H12BClO3 (262.0568)


   

(3-(BENZYLOXY)-5-CHLOROPHENYL)BORONIC ACID

(3-(BENZYLOXY)-5-CHLOROPHENYL)BORONIC ACID

C13H12BClO3 (262.0568)


   

2-CHLORO-N-[4-(DIMETHYLAMINO)PHENYL]PROPANAMIDE HYDROCHLORIDE

2-CHLORO-N-[4-(DIMETHYLAMINO)PHENYL]PROPANAMIDE HYDROCHLORIDE

C11H16Cl2N2O (262.064)


   

Diethyl (4-chlorobenzyl)phosphonate

Diethyl (4-chlorobenzyl)phosphonate

C11H16ClO3P (262.0526)


   

2-(4-TRIFLUOROMETHYLPHENYL)-1H-PYRROLO[2,3-C]PYRIDINE

2-(4-TRIFLUOROMETHYLPHENYL)-1H-PYRROLO[2,3-C]PYRIDINE

C14H9F3N2 (262.0718)


   

3-FORMYL-5-NITRO-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER

3-FORMYL-5-NITRO-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER

C12H10N2O5 (262.059)


   

3-Cyano-2-methyl-6-phenyl-4-(trifluoromethyl)-pyridine

3-Cyano-2-methyl-6-phenyl-4-(trifluoromethyl)-pyridine

C14H9F3N2 (262.0718)


   

(5-(BENZYLOXY)-2-CHLOROPHENYL)BORONIC ACID

(5-(BENZYLOXY)-2-CHLOROPHENYL)BORONIC ACID

C13H12BClO3 (262.0568)


   

4-ALLYL-5-(3-NITROPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL

4-ALLYL-5-(3-NITROPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL

C11H10N4O2S (262.0524)


   

1,3-BIS(2-PYRIDYLTHIO)PROPANE

1,3-BIS(2-PYRIDYLTHIO)PROPANE

C13H14N2S2 (262.0598)


   

ethyl 5-(4-methoxyphenyl)thiophene-2-carboxylate

ethyl 5-(4-methoxyphenyl)thiophene-2-carboxylate

C14H14O3S (262.0664)


   

3-(4-nitro-phenyl)-isoxazole-5-carboxylic acid ethyl ester

3-(4-nitro-phenyl)-isoxazole-5-carboxylic acid ethyl ester

C12H10N2O5 (262.059)


   

Ethyl 5-(3-Nitrophenyl)isoxazole-3-carboxylate

Ethyl 5-(3-Nitrophenyl)isoxazole-3-carboxylate

C12H10N2O5 (262.059)


   

2-BENZYLOXY-5-CHLOROPHENYLBORONIC ACID

2-BENZYLOXY-5-CHLOROPHENYLBORONIC ACID

C13H12BClO3 (262.0568)


   

4-HYDROXY-1-(4-METHOXYPHENYL)-6-OXO-1,6-DIHYDROPYRIDAZINE-3-CARBOXYLIC ACID

4-HYDROXY-1-(4-METHOXYPHENYL)-6-OXO-1,6-DIHYDROPYRIDAZINE-3-CARBOXYLIC ACID

C12H10N2O5 (262.059)


   

5-Fluorouridine

1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-fluoro-pyrimidine-2,4-dione

C9H11FN2O6 (262.0601)


5-Fluorouridine, a metabolite of 5-fluorouracil (HY-90006), is a potent ribozyme self-cleavage inhibitor. 5-Fluorouridine incorporates into both total and poly A RNA and has antiproliferative activity. 5-Fluorouridine induces apoptosis[1][2][3].

   

ethyl 8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate

ethyl 8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate

C12H10N2O5 (262.059)


   
   

ETHYL2-((R)-PYRROLIDIN-2-YL)THIAZOLE-4-CARBOXYLATEHYDROCHLORIDE

ETHYL2-((R)-PYRROLIDIN-2-YL)THIAZOLE-4-CARBOXYLATEHYDROCHLORIDE

C10H15ClN2O2S (262.0543)


   

3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one hydrochloride

3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one hydrochloride

C11H16Cl2N2O (262.064)


   

1-MethyliMidazoliuM sulfobutyrolactone

1-MethyliMidazoliuM sulfobutyrolactone

C9H14N2O5S (262.0623)


   

Chrysene, 2-chloro-

Chrysene, 2-chloro-

C18H11Cl (262.0549)


   

2-chloro-4-(m-tolylamino)pyrimidine-5-carboxamide

2-chloro-4-(m-tolylamino)pyrimidine-5-carboxamide

C12H11ClN4O (262.0621)


   

1,4-Bis-(3-chloro-propoxy)-benzene

1,4-Bis-(3-chloro-propoxy)-benzene

C12H16Cl2O2 (262.0527)


   

Ethyl 5-(3-nitrophenyl)oxazole-4-carboxylate

Ethyl 5-(3-nitrophenyl)oxazole-4-carboxylate

C12H10N2O5 (262.059)


   

(3-(1,3-Dioxolan-2-yl)-5-(trifluoromethyl)phenyl)boronic acid

(3-(1,3-Dioxolan-2-yl)-5-(trifluoromethyl)phenyl)boronic acid

C10H10BF3O4 (262.0624)


   

1-(9H-fluoren-9-yl)-2,2,2-trifluoroethanone

1-(9H-fluoren-9-yl)-2,2,2-trifluoroethanone

C15H9F3O (262.0605)


   

[4-(Benzyloxy)-3-chlorophenyl]boronic acid

[4-(Benzyloxy)-3-chlorophenyl]boronic acid

C13H12BClO3 (262.0568)


   

1-(5-chloro-2-methoxyphenyl)piperazine hydrochloride

1-(5-chloro-2-methoxyphenyl)piperazine hydrochloride

C11H16Cl2N2O (262.064)


   

3-(naphthalen-2-yl)-5-(trifluoromethyl)-1H-pyrazole

3-(naphthalen-2-yl)-5-(trifluoromethyl)-1H-pyrazole

C14H9F3N2 (262.0718)


   

2-[(6-Amino-3,5-dicyano-2-pyridinyl)thio]acetic acid ethyl ester

2-[(6-Amino-3,5-dicyano-2-pyridinyl)thio]acetic acid ethyl ester

C11H10N4O2S (262.0524)


   

2-[(E)-(4-fluorophenyl)methylidene]-6,7-dihydro-5H-[1,3]thiazolo[3,2-a]pyrimidin-3(2H)-one

2-[(E)-(4-fluorophenyl)methylidene]-6,7-dihydro-5H-[1,3]thiazolo[3,2-a]pyrimidin-3(2H)-one

C13H11FN2OS (262.0576)


   

3-{[(2-Furylmethyl)thio]methyl}-4-methoxybenzaldehyde

3-{[(2-Furylmethyl)thio]methyl}-4-methoxybenzaldehyde

C14H14O3S (262.0664)


   

(Rp,sp)-o-(2r)-(1-phenoxybut-2-yl)-methylphosphonic acid chloride

(Rp,sp)-o-(2r)-(1-phenoxybut-2-yl)-methylphosphonic acid chloride

C11H16ClO3P (262.0526)


   

(1s)-1-(Phenoxymethyl)propyl Methylphosphonochloridoate

(1s)-1-(Phenoxymethyl)propyl Methylphosphonochloridoate

C11H16ClO3P (262.0526)


   

Carboxymethyl cellulose

Sodium carboxymethyl cellulose

C8H15NaO8 (262.0665)


   

2-Phenylfuro[2,3-h]chromen-4-one

2-Phenylfuro[2,3-h]chromen-4-one

C17H10O3 (262.063)


   

8-azido-3,8-dideoxy-D-manno-2-octulosonate

8-azido-3,8-dideoxy-D-manno-2-octulosonate

C8H12N3O7- (262.0675)


   

4-chloro-N-(6-methylpyridazin-3-yl)benzohydrazide

4-chloro-N-(6-methylpyridazin-3-yl)benzohydrazide

C12H11ClN4O (262.0621)


   

Theophylline, sodium acetate

Theophylline, sodium acetate

C9H11N4NaO4 (262.0678)


   

3-[(1-Phenyl-5-tetrazolyl)thio]-2-oxolanone

3-[(1-Phenyl-5-tetrazolyl)thio]-2-oxolanone

C11H10N4O2S (262.0524)


   

(2Z)-2-benzylidenebenzo[1,2-b:3,4-b]difuran-3(2H)-one

(2Z)-2-benzylidenebenzo[1,2-b:3,4-b]difuran-3(2H)-one

C17H10O3 (262.063)


   

Bis(2-hydroxypropanoyl) butanedioate

Bis(2-hydroxypropanoyl) butanedioate

C10H14O8 (262.0689)


   

2-(p-Nitrophenyl)-4-ethoxymethyleneoxazol-5-one

2-(p-Nitrophenyl)-4-ethoxymethyleneoxazol-5-one

C12H10N2O5 (262.059)


   

4-(Ethoxymethylidene)-2-(4-nitrophenyl)-1,3-oxazol-5-one

4-(Ethoxymethylidene)-2-(4-nitrophenyl)-1,3-oxazol-5-one

C12H10N2O5 (262.059)


   

Mecadox

Carbadox

C11H10N4O4 (262.0702)


D009676 - Noxae > D002273 - Carcinogens D009676 - Noxae > D009153 - Mutagens D000890 - Anti-Infective Agents

   

Clenproperol

Clenproperol

C11H16Cl2N2O (262.064)


Clenproperol is a β2-adrenergic agonist[1].

   

EIDD-2749

EIDD-2749

C9H11FN2O6 (262.0601)


EIDD-2749 (4'-Fluorouridine) is an orally active RdRp inhibitor. EIDD-2749 effectively blocks the replication of RSV and SARS-CoV-2. EIDD-2749 also exhibits activity against HCV and lymphocytic choriomeningitis virus (LCMV). EIDD-2749 is a promising oral therapeutic candidate for COVID-19 and is also suitable for research on other RNA viruses[1][2][3].

   

4-hydroxybenzyl sulfoxide

NA

C14H14O3S (262.0664)


{"Ingredient_id": "HBIN010521","Ingredient_name": "4-hydroxybenzyl sulfoxide","Alias": "NA","Ingredient_formula": "C14H14O3S","Ingredient_Smile": "NA","Ingredient_weight": "262.32","OB_score": "NA","CAS_id": "189639-17-6","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7818","PubChem_id": "NA","DrugBank_id": "NA"}

   

4-[(4-hydroxyphenyl)methanesulfinylmethyl]phenol

4-[(4-hydroxyphenyl)methanesulfinylmethyl]phenol

C14H14O3S (262.0664)


   

7-phenylfuro[3,2-h]chromen-6-one

7-phenylfuro[3,2-h]chromen-6-one

C17H10O3 (262.063)


   

(4z)-4-(phenylmethylidene)-3,10-dioxatricyclo[7.3.0.0²,⁶]dodeca-1,6,8,11-tetraen-5-one

(4z)-4-(phenylmethylidene)-3,10-dioxatricyclo[7.3.0.0²,⁶]dodeca-1,6,8,11-tetraen-5-one

C17H10O3 (262.063)